RGD肽修饰的异长春花碱-粉防己碱脂质体的制备及体外抑瘤作用研究
2017-10-10居瑞军王晓敏晁建平程岚李学涛
居瑞军,王晓敏,晁建平,程岚,李学涛#
(1.北京石油化工学院制药工程系,北京102617;2.辽宁中医药大学药学院,辽宁大连 116600)
·制剂与工艺·
RGD肽修饰的异长春花碱-粉防己碱脂质体的制备及体外抑瘤作用研究
居瑞军1*,王晓敏2,晁建平1,程岚2,李学涛2#
(1.北京石油化工学院制药工程系,北京102617;2.辽宁中医药大学药学院,辽宁大连 116600)
目的:制备RGD肽修饰的异长春花碱(VRB)-粉防己碱(TET)脂质体,研究其对脑胶质瘤C6细胞的抑制作用。方法:采用薄膜分散法和硫酸铵梯度法制备RGD肽修饰的VRB-TET脂质体,观察其形态和粒径分布,测定其中VRB的含量;以磺酰罗丹明B法分别测定空白靶向脂质体、VRB普通脂质体和RGD肽修饰的VRB-TET脂质体对C6细胞的抑制作用。结果:所制RGD肽修饰的VRB-TET脂质体呈圆球状或类圆球状,表面光滑,粒径为120 nm左右,其中VRB的平均含量为28.27 μg/mL(RSD=0.38%,n=3)。空白靶向脂质体对C6细胞生长无显著影响;RGD肽修饰的VRB-TET脂质体能明显抑制C6细胞生长,其作用后细胞存活率明显低于VRB普通脂质体(P<0.05)。结论:成功制得RGD肽修饰的VRB-TET脂质体,其具有明显的抑制C6细胞生长的作用。
RGD肽;异长春花碱;粉防己碱;脂质体;体外抑瘤作用
ABSTRACTOBJECTIVE:To prepare the vinorelbine-tetrandrine liposomes modified with RGD,and study the inhibitory effect on glioma C6 cells.METHODS:Film dispersion method and ammonium sulfate gradient method were used to prepare the vinorelbine-tetrandrine liposomes modified with RGD,and the morphology and particle size distribution were observed.The vinorelbine content was determined,and sulforhodamine B method was used to respectively determine the inhibitory effects of blank targeting liposomes,normal vinorelbine liposomes and vinorelbine-tetrandrine liposomes modified with RGD on C6 cells.RESULTS:The prepared vinorelbine-tetrandrine liposomes modified with RGD were spherical or almost spherical with smooth surface,and particle size was about 120 nm.The average content of vinorelbine was 28.27 μg/mL(RSD=0.38%,n=3).Blank targeting liposomes had no significant effect on the growth of C6 cells;vinorelbine-tetrandrine liposomes modified with RGD can obviously inhibit the growth of C6 cells,and cell viability after its effect was significantly lower than normal vinorelbine liposomes(P<0.05).CONCLUSIONS:Vinorelbine-tetrandrine liposomes modified with RGD are successfully prepared,and they show obvious inhibitory effects on the growth of C6 cells.
KEYWORDSRGD;Vinorelbine;Tetrandrine;Liposomes;in vitro antitumor effect
异长春花碱(Vinorelbine,VRB)是从长春花[Catharathusroseus(L)G.Don]中提取的一种半合成生物碱。作为细胞周期特异性抗肿瘤药物,VRB主要作用于细胞增殖周期的G1、S及M期[1],并可通过与微管蛋白结合抑制微管聚合,使分裂的细胞不能形成纺锤体而终止细胞分裂,从而起到抑制细胞增殖的作用[2]。VRB在临床上主要用于非小细胞肺癌、急性淋巴细胞白血病、转移性乳腺癌、软组织肉瘤及神经母细胞瘤等多种肿瘤的治疗[3-5]。……
